Clinical Trial Update: Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease [Phase 4]

View source ↗

Summary

Phase 4 trial investigating evolocumab effects on functional status and LDL oxidation in patients with peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Leonardo Clavijo | Conditions: Peripheral Arterial Disease | Phase 4 | Status: UNKNOWN